Escuder-Rodriguez JJ, Liang D, Jiang X, Sinicrope FA. Ferroptosis: biology and role in gastrointestinal disease. Gastroenterology. 2024;167:231–49.
Article PubMed PubMed Central CAS Google Scholar
Liu J, Dong R, Yuan B, Xie Y, Feng Z, Zhou S, et al. Immune cells dying from ferroptosis: mechanisms and therapeutic opportunities. Cell Death Dis. 2025;16:878.
Article PubMed PubMed Central Google Scholar
Sunaga S, Tsunoda J, Teratani T, Mikami Y, Kanai T. Heterogeneity of ILC2s in the intestine; homeostasis and pathology. Front Immunol. 2022;13:867351.
Article PubMed PubMed Central CAS Google Scholar
Liu G, Wang Y, Huang H, Wang J, Yang J, Wu J, et al. GPX4-dependent ferroptosis governs ILC2 homeostasis and colitis progression. Cell Mol Immunol. 2026;23:367–82.
Wientjens C, Doverman M, Zurkovic J, More T, Surendar J, Nesic S, et al. Tolerance to ferroptosis facilitates lipid metabolism and pathogenic type 2 immunity in allergic airway inflammation. Immunity. 2026;59:322–38 e329.
Article PubMed CAS Google Scholar
Li X, He J, Gao X, Zheng G, Chen C, Chen Y, et al. GPX4 restricts ferroptosis of NKp46(+)ILC3s to control intestinal inflammation. Cell Death Dis. 2024;15:687.
Article PubMed PubMed Central Google Scholar
Tsou AM, Yano H, Parkhurst CN, Mahlakoiv T, Chu C, Zhang W, et al. Neuropeptide regulation of nonredundant ILC2 responses at barrier surfaces. Nature. 2022;611:787–93.
Article PubMed PubMed Central CAS Google Scholar
Huang W, Zhang Y, Das NK, Solanki S, Jain C, El-Derany MO, et al. Fibroblast lipid metabolism through ACSL4 regulates epithelial sensitivity to ferroptosis in IBD. Nat Metab. 2025;7:1358–74.
Article PubMed PubMed Central CAS Google Scholar
Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40:365–78 e366.
Article PubMed PubMed Central CAS Google Scholar
Uddin J, Yano H, Parkhurst CN, Zhang W, Ahmed A, Ribeiro de Godoy V, et al. CGRP-related neuropeptide adrenomedullin 2 promotes tissue-protective ILC2 responses and limits intestinal inflammation. Nat Immunol. 2025;26:1516–26.
Comments (0)